[HTML][HTML] Mechanisms underlying the protective effects of mesenchymal stem cell-based therapy

XL Fan, Y Zhang, X Li, QL Fu - Cellular and molecular life sciences, 2020 - Springer
Mesenchymal stem cells (MSCs) have been extensively investigated for the treatment of
various diseases. The therapeutic potential of MSCs is attributed to complex cellular and …

[HTML][HTML] The therapeutic potential of mesenchymal stromal cells for regenerative medicine: current knowledge and future understandings

M Merimi, R El-Majzoub, L Lagneaux… - Frontiers in Cell and …, 2021 - frontiersin.org
In recent decades, research on the therapeutic potential of progenitor cells has advanced
considerably. Among progenitor cells, mesenchymal stromal cells (MSCs) have attracted …

[HTML][HTML] Hypoxia-elicited mesenchymal stem cell-derived exosomes facilitates cardiac repair through miR-125b-mediated prevention of cell death in myocardial …

LP Zhu, T Tian, JY Wang, JN He, T Chen, M Pan… - Theranostics, 2018 - ncbi.nlm.nih.gov
Exosomes (Exo) secreted from hypoxia-conditioned bone marrow mesenchymal stem cells
(BM-MSCs) were found to be protective for ischemic disease. However, the role of exosomal …

[HTML][HTML] Comparative study of extracellular vesicles derived from mesenchymal stem cells and brain endothelial cells attenuating blood–brain barrier permeability via …

Y Li, B Liu, T Zhao, X Quan, Y Han, Y Cheng… - Journal of …, 2023 - Springer
Background Blood–brain barrier (BBB) disruption is a major adverse event after ischemic
stroke (IS). Caveolin-1 (Cav-1), a scaffolding protein, played multiple roles in BBB …

[HTML][HTML] Multicellular crosstalk between exosomes and the neurovascular unit after cerebral ischemia. Therapeutic implications

AM Zagrean, DM Hermann, I Opris, L Zagrean… - Frontiers in …, 2018 - frontiersin.org
Restorative strategies after stroke are focused on the remodeling of cerebral endothelial
cells and brain parenchymal cells. The latter, ie, neurons, neural precursor cells and glial …

[HTML][HTML] Engineered exosomes: desirable target-tracking characteristics for cerebrovascular and neurodegenerative disease therapies

M Xu, T Feng, B Liu, F Qiu, Y Xu, Y Zhao, Y Zheng - Theranostics, 2021 - ncbi.nlm.nih.gov
As extracellular vesicles secreted by cells, exosomes are intercellular signalosomes for cell
communication and pharmacological effectors. Because of their special properties, including …

Application of mesenchymal stem cell-derived extracellular vesicles for stroke: biodistribution and microRNA study

GJ Moon, JH Sung, DH Kim, EH Kim, YH Cho… - Translational stroke …, 2019 - Springer
Mesenchymal stem cells (MSCs) exert their therapeutic capability through a variety of
bioactive substances, including trophic factors, microRNAs, and extracellular vesicles (EVs) …

Mesenchymal stem cell-derived extracellular vesicle-based therapies protect against coupled degeneration of the central nervous and vascular systems in stroke

A Rahmani, K Saleki, N Javanmehr… - Ageing research …, 2020 - Elsevier
Stem cell-based treatments have been suggested as promising candidates for stroke.
Recently, mesenchymal stem cells (MSCs) have been reported as potential therapeutics for …

[HTML][HTML] Extracellular vesicle-based therapy for COVID-19: Promises, challenges and future prospects

V Karn, S Ahmed, LW Tsai, R Dubey, S Ojha, HN Singh… - Biomedicines, 2021 - mdpi.com
The COVID-19 pandemic has become a serious concern and has negatively impacted
public health and the economy. It primarily targets the lungs, causing acute respiratory …

In vivo monitoring and assessment of exogenous mesenchymal stem cell-derived exosomes in mice with ischemic stroke by molecular imaging

R Xu, Y Bai, S Min, X Xu, T Tang… - International Journal of …, 2020 - Taylor & Francis
Purpose Mesenchymal stem cell-derived exosomes (MSC-exos) are considered an
important restorative treatment for ischemic stroke. However, the migration ability and …